Ethical and Regulatory Aspects of Personalized Medicine
Most of the ethical aspects of personalized medicine are based on pharmacogenetics, genetic screening and impact on healthcare. Understanding the social effects of genomics requires an analysis of the ways in which genetic information and a genetic approach to disease affect people individually, within their families and communities, and in their social and working lives. This information will lead to measures for the prevention of stigmatization and discrimination of different populations on ethnic grounds.
KeywordsCritical Path Personalized Medicine National Human Genome Research Institute Companion Diagnostics Pharmacogenomic Testing
- Caulfield T, McGuire AL, Cho M et al (2008) Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol 6:e73.Google Scholar
- Jain KK (2009a) Molecular diagnostics: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.Google Scholar
- Lesko LJ, Woodcock J (2004) Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov 3:763–769Google Scholar